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ABSTRACT
 Biodegradation of Bisphenol A and Ibuprofen
by Ammonia Oxidizing Bacteria. (May 2007)
Nethra T. Subramanya, B.E, Visvesvaraya Technological University, India
Chair of Advisory Committee: Dr. Kung-Hui Chu
       Bisphenol A (BPA) is a compound that is commonly used in the manufacture of 
epoxy resins and plastics. Because of large scale production and widespread usages, 
BPA is released into the atmosphere through air, land, and water. BPA is weakly 
estrogenic in animals and has acute aquatic toxicity even at low concentrations of 1-
10μg/L. Ibuprofen is a widely used analgesic and antipyretic. Ibuprofen and its 
metabolites are mainly released into the environment by human urinary excretion. 
Ibuprofen has been detected at low concentrations in surface and waste waters. The 
environmental and health effects at such concentrations are unclear.
      The high removal of BPA and ibuprofen in the wastewater treatment plants 
(WWTPs), suggest that biodegradation might be responsible for the removal of these 
compounds. Several bacterial strains, isolated from waste water, are known to degrade
BPA and ibuprofen. No studies, however, have reported using ammonia oxidizing 
bacteria for this purpose. Ammonia oxidizing bacteria (AOB) are an important group of 
microorganisms in nitrifying activated sludge of WWTPs. AOB are known to express 
ammonia monooxygenase (AMO) to degrade many different aromatic and aliphatic 
organics via cometobolic degradation (non beneficial mechanism). Nitrosomonas 
europaea is a widely studied AOB found to degrade synthetic estrogen by a study.
      This study aims to characterize the biodegradation of BPA and ibuprofen by AOB. 
The biodegradation ability of N.europaea with respect to BPA and ibuprofen was 
examined. Experiments were conducted in the presence/absence of the AMO inhibitor 
(allylthiourea), an external reducing energy source (sodium formate) and different 
iv
primary substrate (ammonia) concentrations. The second part of the study comprises of 
biodegradation tests on BPA and ibuprofen using activated sludge from two WWTPs, 
one with one-sludge activated sludge system and the other one with two-sludge 
nitrification system.
       From the experiments conducted BPA at a concentration of 1.6 mg/L was 
degraded to 0.12 mg/L by N.europaea. BPA at concentrations of 1.0 mg/L and 0.75 
mg/L was completely degraded by the cells. Resting cells of N.europaea were, however,
unable to degrade BPA. Also ibuprofen of two concentrations, 0.42 mg/L and 0.8 mg/L,
were not degraded by the culture. 
       BPA at a concentration of 1 mg/L was degraded to 0.2 mg/L and ibuprofen at 0.5 
mg/L was completely degraded by the activated sludge from the combined reactor. The 
activated sludge from the nitrification tank degraded BPA of concentration 1 mg/L and 
ibuprofen of concentration 0.5 mg/L completely.
  Hence, it can be summarized that Bisphenol A was degraded by N.europaea and 
also by the activated sludge obtained from the WWTPs. Ibuprofen was found incapable 
of inhibiting ammonia oxidizing bacteria in the case of the pure culture while it was 
successfully degraded by the mixed culture.
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1CHAPTER I1
INTRODUCTION
     Bisphenol A (BPA) is an intermediate product in the manufacture of compounds
like plastics, epoxy resins and polycarbonate resins [1]. BPA was first discovered in the 
year 1905 and since then its commercial popularity has increased gradually with time.
Presently BPA is being used in a number of products like adhesives, building materials, 
powder paints, inner coating of cans, automotive lenses, compact discs, thermal paper, 
for encapsulation of electrical and electronic parts and so on [49]. Production of BPA in 
2001 alone was approximately equal to 2.5 million tons which increased to 2.8 million 
tons in the year 2002 [50, 1].  
      BPA is detected in surface waters at a concentration up to 0.4 μg/L [3]. BPA is 
released into the environment during manufacturing processes like heating, handling and 
transportation. Accidental spills and leakages are also a major source. BPA is known to 
leach specifically from plastic products, most prominent being poly vinyl chloride [7]. 
BPA causes acute toxicity to aquatic organisms between concentrations of 1-10 μg/L [2]. 
BPA is also an endocrine disrupter and studies have confirmed its estrogenicity and 
effects on the behavior of mice [8, 29, 43]. Removal of BPA by wastewater treatment 
plants (WWTPs) has been reported to be greater than 90% [11, 49]. Several bacterial 
strains isolated from wastewater can use BPA as a growth substrate [20, 22, 23, 32, 43].
      Ibuprofen is a popular chiral pharmaceutical drug classified as a non-steroidal anti-
inflammatory drug (NSAID) [42]. Ibuprofen is used as an analgesic, antipyretic and 
against anti-inflammatory conditions. Ibuprofen is one of the many pharmaceutical 
compounds that are increasingly being detected in influents to WWTPs. Ibuprofen is
persistent and mobile in the aquatic environment because of its physical and chemical 
properties. Ibuprofen is used extensively as a pharmaceutical drug since it can be 
obtained without a prescription [42]. Ibuprofen’s concentration in surface waters has 
been reported to be between 2-8 ng/L in most lakes, with some German rivers containing 
up to 139 ng/L [42].
                                                
This thesis follows the style of Journal of Applied and Environmental Microbiology (AEM).
2    There is growing concern regarding the increasing presence of ibuprofen and its 
metabolites in WWTPs and surface waters. Ibuprofen is known to effect the growth of 
certain species of aquatic plants, Synechocystis sp. and Lemna minor [39]. However 
information on its environmental and health effects at low concentrations is limited and 
unclear.
       The WWTPs are capable of removing approximately 95% of ibuprofen and its 
metabolites [42]. Studies conducted in the laboratory by incubating WWTP samples 
indicate the biodegradation of ibuprofen [42]. However there are a limited number of 
studies conducted on the biodegradation of ibuprofen. One study reported ibuprofen 
degradation by a bacterial strain belonging to the species Nocardia [5]. Another study 
isolated a Sphingomonas sp. strain from wastewater as being capable of degrading 
ibuprofen [37]. In both studies ibuprofen was used as a growth substrate by the bacterial 
strains.
      The biodegradation of both BPA and ibuprofen has been described in earlier 
research [5, 20, 22, 23, 32, 37, 43]. The present study is aimed at examining the 
degradation possibilities of both these compounds by AOB. Ammonia oxidizing bacteria 
(AOB) are important microorganisms found in the nitrifying activated sludge of 
WWTP’s known to degrade several compounds [25].  Studies have reported a wide 
substrate range for these bacteria which includes both aromatic and aliphatic compounds 
[5]. Nitrosomonas europaea, a highly researched AOB is known to degrade synthetic 
estrogens as per a recent study [46]. However no study has focused on utilizing the AOB 
and N.europaea for degrading BPA and ibuprofen.
     This study is based on the hypothesis that ammonia oxidizing bacteria might play 
an important role in removing BPA and ibuprofen via cometabolism during biological 
wastewater treatment.
31.1 GOAL AND OBJECTIVES
The goal of this study is to understand the biodegradation of both BPA and ibuprofen by 
AOB. The main objectives of the study are:
1. To characterize the co-metabolic degradation of BPA and ibuprofen by an 
ammonia oxidizing bacterium, Nitrosomonas europaea.
2. To study the biodegradation of BPA and ibuprofen by ammonia oxidizing 
bacteria from the nitrifying activated sludge collected from two waste water 
treatment plants.
The following chapters cover more information on the two compounds, the ammonia 
oxidizing bacteria, the experimental materials and methods, results and discussion.
4CHAPTER II
BACKGROUND
2.1 PHYSICAL AND CHEMICAL PROPERTIES
2.1.1 BPA. BPA is an aromatic compound that is synthetically manufactured and used as 
a chemical building block in the manufacture of several products [1]. These products are 
light-weight, resistant to high temperatures, tough and adhesive in nature; making BPA a 
highly useful industrial compound [1].  
       The structure of BPA consists of two phenol groups with two methyl groups 
connecting them (Table 1) [49]. BPA occurs as a solid at room temperature and standard
pressure in the form of prills, flakes and crystals [49]. BPA has a low volatility (lesser 
than water) as compounds with Henry’s constant < 1.0E-7 atm-m3/mol (Table 1) are 
considered to be less volatile [15, 49]. 
     BPA has greater solubility at alkaline pH [15, 49]. It is considered to be 
hydrophobic and is known to partition to soils and sediments [7]. However some part of 
it is present dissolved in the aqueous phase based on the concentration [3]. BPA is not 
known to ionize in the environment with pH values around 7.0 since it has a pKa value 
between 9.59 and 11.30 [7]. But BPA can ionize under alkaline conditions that are 
normally prevalent in the industries [7].
2.1.2 Ibuprofen. Ibuprofen is an aromatic compound that is manufactured to be used as 
a drug in the pharmaceutical industry. Ibuprofen was first discovered in Nottingham, 
England by Dr. Stuart Adams, John Nicholson and Collin Burrows [15]. Ibuprofen is an 
ingredient in some common drugs available in the market like Deep Relief, Nurofen, 
Nurofen gel and Nurofen Plus used to treat common ailments like fever, pain and 
rheumatic disorders [15, 42]. Ibuprofen specifically is used to treat pains that occur due 
to menstruation, headaches, inflammatory conditions like rheumatoid arthritis and some 
common ailments like fever [16]. It is prescribed in high dosages of the order of 600-
1200 mg/d [42]. Around 70-80% of the dosage prescribed is released into the 
environment through excretion. Along with Ibuprofen, four other metabolites have also 
been detected in the environment [42].
5      Ibuprofen has a propionic acid group attached to its structure (Table 1) [16]. 
Ibuprofen has a molecular weight of 206.29 g/mol with a CAS number 15687-27-1 [16]. 
Ibuprofen occurs as a white crystalline powder at room temperature and standard 
pressure [16]. Ibuprofen is reported to be practically insoluble in water [16]. Ibuprofen 
has a melting point between 75°C-78°C and is a relatively stable compound at room 
temperature and standard pressure [16].
     Ibuprofen has two enantiomers namely the S-ibuprofen and R-ibuprofen as shown 
in Table 1 [42]. During the metabolism in the body R-ibuprofen is converted into the 
pharmacologically active S-enantiomer [42].
TABLE 1. Structure and chemical properties of BPA and ibuprofen.
Property BPA Ibuprofen
Figure 
[59, 16]
Structure of ibuprofen enantiomers
Chemical 
formula 
[49, 16]
C15H16O2 (CH3)2CHCH2C6H4CH(CH3)COOH
Molecular
weight
[49, 16]
228 g/mol 206.29 g/mol
6TABLE 1. Continued.
CAS 
Number
[49, 16]
80-05-7 15687-27-1
Solubility
[49, 16]
120-300mg/L Practically insoluble
Melting point
[15, 16]
150°C-155°C 75°C-78°C
Boiling point
[15]
220°C at 4mm of Hg -
Henry’s 
constant [15]
1.0E-10 atm-m3/mol -
Koc [15] 314-1584 at water solubility of 
120 mg/L
-
2.2 ENVIRONMENTAL SOURCES, OCCURRENCE AND FATE
2.2.1 BPA. BPA enters the environment through several pathways. BPA is released into 
the environment during the manufacturing process (particularly during heating, handling, 
transporting the material and accidental spills) [49]. BPA is known to have a low vapor 
pressure of 5.3x 10-6 Pa. During the manufacturing processes, it is heated to high 
temperatures at which it is released in the vapor form to the atmosphere [7]. BPA being
moderately soluble in water enters into the environment by the wastewater generated 
during the manufacturing process. The wash water used is another major source [7]. 
Despite the treatment of these waste waters, complete removal of BPA is not ensured. 
Due to BPA’s low air water partition coefficient of 10-9, the BPA in water does not 
evaporate [7].
      BPA also enters the environment by the disposal of the products in which it is used
like the lining of cans or from plastic products [49]. BPA enters the soil from the 
leachates of waste landfills which have a BPA concentration of 1.3-17,200 μg/l [59].
7According to the US Toxics Release Inventory (TRI), 85,300 kg is released through 
fugitive and stack emissions, about 3500 kg is directly released to water, 1100 kg is 
released by effluents from WWTPs (> 90% removal) and 10,000 kg to water from 
thermofax paper, landfills, leakages from linings of pipes, products that are not landfilled 
and dust formation was reported by Cousins, Staples, Klecka and Mackay in 2002 [7].
      Approximately around 65% of the produced BPA is used in the manufacture of 
polycarbonate resins, 28% in epoxy resins and the remaining 7% is used in other 
miscellaneous products [7]. BPA emissions from various point sources were detected 
ranging from 2.1 μg/L to 41 μg/L according to a study (Table 2) [11]. The samples were 
taken across ten sampling sites with four times a day, five days a week within a period of 
five months to overcome fluctuations [11].
TABLE 2. Average emissions of BPA from various point sources. [11]
Sample spots Mean 
concentration
(μg/L)
Minimum value Maximum value
Metal/wood 
industry
17 2.6 35
Chemical industry 18 2.5 50
Hospital non detectable non detectable 1.0
Paper production 41 28 72
Cloth washing 
company
5.2 1.0 8.9
Food industry 2.1 non detectable 3.8
Household areas I 2.2 non detectable 2.6
Household areas II 2.5 non detectable 5.8
Influent 21 10 37
Effluent 1.5 non detectable 2.5
         
82.2.2 Ibuprofen. Ibuprofen is produced on the order of several kilotons every year all 
over the world as indicated in Table 3 [13, 26, 48, 53, 54, 55]. Ibuprofen has the 
distinction of being the third most popular drug by usage and sales [41].
TABLE 3. Ibuprofen usage across countries. [13, 26, 48, 53, 54, 55].
Country/ Year Quantity (ton/yr)
United Kingdom/ 2000 162
Denmark/ 1997 34
Deutschland 105-180
Australia 14
United States Not available
        
     As ibuprofen is used as a drug, it is partly or fully metabolized in the body [12]. 
During the metabolism, the parent compound is normally converted into metabolites that 
could prove to be more or less harmful than the parent compound [12]. Urine tested from 
a patient who had been administered with ibuprofen showed the presence of metabolites 
like methyl esters of ibuprofen, carboxy- IB (major), hydroxyl- IB and carboxy-
hydratropic acid (carboxy- HA) [42]. Usually the metabolites are more water soluble 
than the parent compound [12]. Both the parent compound and the metabolites are 
released into the environment through urine [12].          
      Ibuprofen is prescribed in high dosages of 600-1200 mg/d and it can also be 
bought without a prescription [42]. Around 70-80% of this therapeutic dose enters the 
environment due to excretion [42]. Ibuprofen can also be released into the environment 
due to the direct disposal of outdated or excess medication [12]. Ibuprofen was detected 
up to a concentration of 3μg/ L in the influents to WWTPs. However in surface waters 
they can be detected at a concentration of 8 ng/L [42].
      A study conducted on the water systems and rivers in Italy reported the presence 
of ibuprofen in river water, river sediments and drinking water [61]. Ibuprofen was 
9detected in a wide cncentration range of 1.0 ng/L to 92.4 ng/L in the three major rivers
[61]. In one of the river sediments ibuprofen was detected up to 220 ng/kg [61]. 
However it was not detectable in the drinking water systems of any of the major cities 
investigated [61].   
2.3 TOXICITY 
2.3.1 Toxicity of BPA to ecosystem. BPA is toxic to both freshwater and saltwater 
species [2]. The following Table 4 summarizes BPA toxicity to freshwater and saltwater 
species.
TABLE 4. Aquatic toxicity to freshwater and saltwater species. [2]
Freshwater species Toxicity
Selenastrum capricornutum 96 hour EC50 based on cell count was 2.7 
mg/L, based on cell volume 3.1 mg/L.
Daphnia magna 48 hour EC50, 10 mg/L 
Pimephales  promelas 96 hour LC50 in static test 4.7 mg/L and in  
flow through test 4.6 mg/L
Saltwater species Toxicity
Skeletonema costatum 96 hour EC50 based on cell count 1 mg/L 
and based on chlorophyll-a content 1.8 
mg/L.
Mysidopsis bahia 96 hour LC50, 1.1mg/L
Menidia menidia 96 hour LC50, 9.4 mg/L
          
2.3.2 Toxicity of BPA to animals. One study confirms the estrogenicity of BPA due to
which it binds to estrogen receptors in rat uterus [30]. According to Yoshihara et al, BPA 
of 0.1 mM (or 22.8 mg/L) concentration increased the estrogenicity in rats by two to five 
10
folds [34]. BPA is reported to increase the height of the luminal epithelial cells in the 
uterus and also increase the vaginal openings in female mice [34]. 
  BPA also induces progesterone receptors in cancerous mammary cells in human 
beings [30]. A study on pregnant human mothers exposed to BPA detected significant 
levels of BPA in the blood and plasma of both the mother and the fetus [44]. BPA levels 
in the maternal plasma, fetal plasma and placental tissue were found to be 3.1 ng/mL, 2.3 
ng/mL and 12.7 ng/g respectively [44]. Exposures of animals to similar concentrations 
were known to affect some organs of the offspring [30]. BPA is also known to induce 
depression like behavior in male rats and reduces the sexual differences in rearing 
behavior [10].
      The average environmental concentration of BPA in surface waters is 0.41 μg/L 
[3]. However the toxicity concentrations reported range from 2.3 mg/L to 22.8 mg/L [10, 
30, 34, 44]. A difference of the order of 103 exists between the environmental and 
toxicity concentrations of BPA.
2.3.3 Toxicity of ibuprofen to ecosystem. Ibuprofen is currently detected in low 
concentrations in the environment with the maximum detected concentration being 8 
ng/L [42]. Information on the effects of ibuprofen on the human health and its toxicity is 
limited. Though in a broader sense, it is known that pharmaceuticals are manufactured to 
perform a specific biological action [12]. This could either be useful or harmful to other 
organisms when they are released into the environment [12]. They are also lipophilic and 
hence are able to travel across different membranes [12]. 
       Ibuprofen is known to affect certain species of aquatic plants like Synechocystis 
and Lemna [40]. While ibuprofen stimulates the growth of Synechocystis at a 
concentration of 10 μg/L, it is known to inhibit the growth of Lemna at 1 mg/L [39]. 
Also exposure to ibuprofen resulted in the production of the stress hormone abscisic acid 
in Lemna [39]. Ibuprofen along with certain other chemicals is also known to be harmful 
to aquatic organisms. A study reported the harmful effect of a mixture of ibuprofen, 
prozac and ciprofloxacin on certain aquatic plants, planktons and fish at concentrations 
lower than the human dosage of 600-1200 mg/d [39, 41]. It was observed that the 
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mixture caused the death of certain species of plankton, sunfish (Lepomis gibbosus) and 
duckweed (Lemna gibba) [41].
2.3.4 Toxicity of ibuprofen to animals. Ibuprofen is also known to hinder the 
cardiovascular protective properties of aspirin (both less than 325 mg/day) consumed by 
patients with cardiovascular problems [33]. The study was conducted on cardiovascular 
patients who were administered with aspirin at low dosages [33].
         The concentration of ibuprofen of upto 7.8 ng/L was reported for 8 lakes including 
the North Sea [42]. The toxicity concentrations vary between 10 μg/L to 1 mg/L [39]. 
Hence a difference of magnitude 103 to 106 between the environmental and toxicity 
concentrations is present. This reduces the magnitude of the risks posed by ibuprofen to 
the ecosystem.
2.4 REMOVAL OF BPA AND IBUPROFEN
2.4.1 BPA. Removal of BPA occurs by both biotic and abiotic processes which are 
summarized below.
2.4.1.1 Biodegradation:
A. Surface water and WWTP. The biodegradation of BPA has been the focus of 
several studies as opposed to alternate chemical and physical methods of treatment [9, 
32, 47]. BPA is known to be biologically degraded rapidly in surface waters with an 
average half life of below 5 days [22].
       Several aerobic BPA-degrading bacterial strains have been isolated from river 
water and WWTPs [32, 43, 47]. Two bacterial strains Pseudomonas sp. and 
Pseudomonas putida that degraded BPA by more than 90% were isolated from river 
water [22]. Under aerobic conditions, BPA degradation was > 90% at the end of 7 days 
compared to a BPA degradation of < 10% after 10 days under anaerobic conditions [22].
        A study was conducted on the BPA released by various industries into the Houston
ship channel [9]. Water samples from Houston ship channel were spiked with BPA in 1 
gallon water columns with air inlets at the bottom and sterililzed water was used as the 
control [9]. The experiment was conducted in the dark [9]. Degradation in most of the 
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samples was observed after two days with the concentrations of BPA falling below 
detectable limits on the 4th day [9]. This reduction was attributed to biodegradation as 
there was no exposure to UV light or changes in the pH of the samples [9].
Approximately 96-97% of BPA added was degraded within 3 days [9]. Some studies 
have successfully isolated bacterial strains that are capable of degrading BPA and the 
various parameters involved in the process. One study reports that an increase in the 
sludge retention time in WWTPs beyond 40 days does not have any positive effect on 
the biodegradation of BPA [29]. The ensuing section covers more information on the 
BPA degrading bacterial strains. 
B. Soil. Since BPA has a high octanol-air partition coefficient it tends to sorb on to solid 
surfaces, vegetation, soils and aerosols [49]. BPA degradation in soil sediments is 
reported to have a half life of less than 3 days [36]. Metabolites of BPA were also 
successfully degraded in the soil [36]. Most of the BPA loss was attributed to aerobic 
biodegradation while a part of the loss was due to incorporation in the soil organic 
matter [36]. No data regarding the effect of UV on BPA in soil is available.
2.4.1.2 Abiotic removal of BPA. Apart from biodegradation, several abiotic processes 
have also been used in the treatment of BPA in WWTP’s. Chemical degradation of BPA 
also occurs in the environment by photodegradation [15].
A. Chemical method. Chemical methods have been applied successfully in the 
pretreatment of BPA in wastewater. One study reported more than 85% removal of BPA 
by applying pH neutralization [8]. Chemical methods like ozonation and chlorination 
have also been used for the removal of BPA in drinking water treatment. BPA of 
concentration 500- 300,000 ng/L was treated with ozonation (1.4 mg/L O3) and 
chlorination with sodium hypochlorite (0.5 mg/L) and chlorine dioxide (0.4-0.6 mg/L) 
[31]. Ozonation followed by chlorination removed BPA below detectable limits [31]. 
Ozonation combined with sodium hypochlorite treatment also ended in the same results 
but with an increase in the estrogenic activity [31].
B. Photodegradation. BPA is also degraded by photodegradation in surface waters and 
in the atmosphere [15]. This process is called photolysis or photooxidation [15]. BPA is 
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known to absorb UV light of wavelengths greater than 290 nm [15]. This alters the 
chemical properties of BPA. In the atmosphere BPA is subject hydroxyl radical attacks 
as well [15]. With respect to photodegradation BPA is known to have a half life of 66 
hours to 160 days in water and 0.74 to 7.4 hours in air [15].
C. Physical methods. More than 85 % BPA removal was observed by precipitate 
filtration and XAD resins [8]. Use of different nanofilters for the removal of BPA 
reported a removal of 70% to 100% [58]. Other technologies like membrane bioreactors 
and reverse osmosis met with 98% removal [58]. Treatment by membrane bioreactors 
accompanied by the use of granulated activated carbon resulted in 99% BPA removal 
[58].
2.4.2 Ibuprofen. Most of the literature provides data about ibuprofen in water with no 
available data about ibuprofen’s occurrence soil and air.  Both ibuprofen and its 
metabolites in urine were detected in the wastewater influents [42]. Ibuprofen was 
detected at a concentration of 3.3 μg/L in the influent, while the metabolites hydroxyl-IB 
and carboxy- IB were found at higher concentrations and hydroxyl-IB was found in 
lower concentration [42]. Effluent concentrations of ibuprofen, carboxy-IB and 
hydroxyl-IB were detected at a much lower range 9 to 81 ng/L [42]. This indicated that 
ibuprofen was efficiently removed by WWTPs.
         It was found that ibuprofen and carboxy-IB dominated the raw sludge while 
hydroxyl-IB was more prominent in the treated waters [38]. In a WWTP that had
primary settling, chemical removal of phosphorous, activated sludge and biological 
nitrogen removal processes, the removal of ibuprofen and carboxy-IB was more than 
95% [38]. The removal of hydroxyl-IB was reported to be 60% due to the formation of 
40% hydroxyl-IB during the removal process [38]. Additionally disturbances in a 
WWTP with only primary settling and activated sludge processes resulted in a lower 
removal (43%) of ibuprofen and almost no removal of hydroxyl-IB [38]. However this 
did not seem to affect the removal of carboxy-IB [38].
2.4.2.1 Biodegradation. Biodegradation is known to be the main process for removal of 
ibuprofen from the environment with the formation of polar metabolites in WWTPs [38].
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While the biodegradation of ibuprofen has been reported several times in the WWTP’s, 
only two ibuprofen degrading cultures were reported. One study conducted earlier 
reported the side chain hydroxylation of the compound in biofilm reactors [62]. This was 
observed to occur under both aerobic and anaerobic conditions resulting in the 
degradation of ibuprofen with the formation of metabolites [62]. 
       Degradation tests of ibuprofen with activated sludge conducted in the laboratory 
resulted in a decrease in the concentration after a period of 8 hours [42]. Influent to a 
WWTP containing ibuprofen and its metabolites were mixed with the activated sludge 
by air diffusion from the same WWTP in glass bottles [42]. The S-enantiomer is 
degraded at a faster while the R-enantiomer is more persistent [42].The study also 
reported a retention time of more than 6 hours for the efficient degradation of ibuprofen 
[42]. Tests conducted on fortified lake water also reported similar results with the S-
enantiomer being degraded faster than the R-enantiomer. The degradation occurred both 
in daylight and during the night [42]. 
         Another laboratory study reports that increased sludge retention time resulted in 
enhanced degradation of ibuprofen [52]. However there was no such conclusion from the 
study conducted on the full scale plants [52]. This study also reported the near complete 
removal of ibuprofen in WWTPs, specifically in the ones that were designed for nitrogen 
removal or for nitrification [52]. The complete removal was consistent both in the case 
of full scale plants as well as laboratory experiments [52].
2.4.2.2 Abiotic (physical) processes. A study was conducted to use ozonation, 
nanofiltration, microfiltration and reverse osmosis to remove pharmaceuticals like 
ibuprofen from treated wastewater for water recycle [27]. Ibuprofen of concentration 8 
mg/L was used in the study. Reverse osmosis was observed to be the most successful 
amongst the four methods that were used [27]. While the other processes only reduced 
the concentration of ibuprofen between 0.36 μg/L to 1.88 μg/L, ibuprofen was non 
detectable after reverse osmosis treatment [27].
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2.5 KNOWN BPA AND IBUPROFEN DEGRADING BACTERIA
2.5.1 BPA degrading bacteria. Few strains of Sphingomonas sp. have been found to be 
capable of degrading BPA [43]. Strain AO 1 is a rod shaped aerobic bacterium. Strain 
AO 1 can use BPA as a growth substrate [43]. The cytochrome P450 system is known to 
be responsible for the degradation [43]. 
        The MV1 strain isolated from a WWTP of a plastic manufacturing industry was 
able to utilize BPA as a sole carbon source [32]. During the degradation process several 
intermediates were detected. They were, 4-hydroxyacetophenone (4-HAP), 2, 3-bis (4-
hydroxyphenyl)-1, 2-propanediol (BHPPD), 2, 2-bis (4-hydroxyphenyl)-1- propanol 
(BHPP) and 4-hydroxybenzoic acid (4-HBA) [32]. Of these metabolites, 4-HAP and 4-
HBA were initially formed and were the major metabolites [32]. This was followed by 
the production of BHPP and BHPPD [32]. It was observed that 4-HAP and 4-HBA were 
able to support the growth of the cells after BPA was depleted while the other two 
metabolites could not [32].
        BPA degrading strains were isolated from activated sludge (11 strains) and river 
water (8 strains) [20]. BPA removal by all the strains was 100%. In addition to the 
previously mentioned metabolites, 4, 4-dihydroxy-a-methylstilbene and p-
hydroxyphenacyl alcohol were detected [20]. Some of the bacterial isolates were 
identified as belonging to Arthrobacter, Pseudomonas and Enterobacteriaceae [20].
        Streptomyces.sp was isolated from river water in one other study and this could 
degrade BPA > 90% over a span of 10 days [23]. The half life of BPA degradation by        
Streptomyces.sp was found to be between 3 and 4 days [23]. The bacterial count was 
also found to increase over the first five days, after which there was a drop in the count 
till the tenth day [23].
       The bacterial strains that are capable of degrading BPA are briefly summarized 
below in Table 5. From Table 5, it can be observed that all strains, except Sphingomonas 
bisphenolica, have utilized BPA as a sole carbon source at concentrations much higher 
than the environmental concentration of 0.4 μg/L [4].
16
TABLE 5. BPA degrading bacteria. [20, 22, 23, 32, 43]
Bacteria Growth substrate Conditions
Sphingomonas 
bisphenolica strain 
AO1 [43].
BPA (115 μg/L) used 
as sole carbon source. 
BPA was added to basic mineral salts 
medium at 115μg/l and cultivated at 
30°C in 500ml flasks in 100ml medium 
at 20 rpm.
Bacterial strain 
MV1 with ID no 
NRRL-B-18737
[32].
Cells were grown with 
BPA (342mg/L), 
Glucose and 4-
HydroxyBenzoic 
Acid.
MV1 strains grown on different carbon 
sources were used. 25 ml of PAS basal 
mineral salts medium in 50 ml 
Erlenmeyer flasks. They were incubated 
at 30°C on rotary shakers at 200rpm 
with BPA concentration of 1.5mM.
Pseudomonas sp. 
and Pseudomonas 
putida strain [22].
BPA (1mg/L) used as 
sole carbon source.
1ml of 200mg/l BPA stock solution + 
1ml working culture solution diluted to 
200 ml to get a concentration of 1mg/l. 
Control comprised of 1ml of 200mg/l 
BPA stock solution + bacteria free 
Mueller Hilton broth diluted to 200 ml. 
Bottles covered with nonabsorbent 
cotton wool stored at 30°C.
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TABLE 5. Continued.
Streptomyces sp. 
strain
[23].
BPA (1mg/L)
used as sole 
carbon source.
1 ml aliquot of 200mg/l BPA stock solution + 
1ml working culture solution diluted to 200 ml 
to get a concentration of 1mg/l. Control 
comprised of 1ml of 200mg/l BPA stock 
solution + 1 ml of nutrient broth. All bottles 
were covered with nonabsorbent cotton wool 
and stored at 30°C.
Isolates belonging 
to Arthrobacter, 
Pseudomonas and 
Enterobacteriaceae
[20].
BPA
(1200mg/L)
used as sole 
carbon source.
(i) Sludge pellets washed in 50mM phosphate 
buffer (pH 7.2) suspended in 50ml BPA 
medium and de-ionized water at 1200mg/l on 
shaker at 120 strokes/min at 30°C. 1 ml 
samples were taken, centrifuged and then the 
concentrations were measured.
(ii) 5 ml of 10 times-concentrated river water 
microcosm + 45 ml of artificial river water + 1 
ml of BPA solution in 100 ml Nessler tube. 
Incubated at 28°C in dark at 120 rpm rotary 
shaking. Aliquots taken at regular intervals for 
total organic carbon measurement.
2.5.2 Ibuprofen degrading bacteria. Another study isolated a bacterial strain from the 
WWTP that was capable degrading ibuprofen. The strain Sphingomonas sp. Ibu-2 
isolated from a WWTP was able to utilize ibuprofen as a main carbon source and energy 
source [37]. Both the S-enantiomer and the R-enantiomer of ibuprofen were metabolized 
but there was a slight preference towards the R-enantiomer [37]. Isobutylcatechol was 
produced during the degradation of ibuprofen by Sphingomonas sp. Ibu-2 [37]. The 
propionic acid group was removed and deoxygenation at the 1, 2 positions on the 
aromatic ring of ibuprofen occurred [37]. 
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          A bacterial strain Nocardia sp. strain NRRL 4656 was also found to degrade 
ibuprofen [5]. Both the enantiomers were removed completely [5]. Two principal 
metabolites namely ibuprofenol and ibuprofenol acetate were observed during 
degradation [5]. The biodegradation pattern observed for both the enantiomers were 
slightly different [5]. In the case of the R-enantiomer, both the metabolites could be 
detected [5]. While in the case of the S-enantiomer, only ibuprofenol could be detected
[5].
          Both strains can grow on ibuprofen as the sole carbon source at concentrations 
ranging from 500 mg/L to 250 μg/L. However, the environmental concentrations of BPA
ranged from 2 to 139 ng/L (Table 6).
TABLE 6. Ibuprofen degrading bacteria. 
Bacteria Growth substrate Conditions
Sphingomonas 
sp. strain Ibu-2
[37].
Uses ibuprofen
(500mg/L) as sole 
carbon source.
Active culture was added to 1 liter of MSM
media with 500 mg of Ibuprofen and 
maintained for 48h-60h. Supernatant acidified 
to pH 3 with HCl and extracted with ethyl 
acetate for GCMS analysis.
Nocardia sp. [5] Uses ibuprofen
(250μg/L) as sole 
carbon source.
Culture grown on soyabean meal-glucose 
medium and ibuprofen substrate. Culture 
added to five1 liter DeLong flasks containing 
200 ml media. 1 g ibuprofen distributed 
amongst the five flasks.
2.6 AMMONIA OXIDIZING BACTERIA (AOB)
2.6.1 Introduction. The AOB are chemolithoautotrophic bacteria that play an important 
role in the nitrogen cycle oxidizing ammonia to nitrate, the first step of nitrification [40].
The nitrification process is commonly employed in wastewater treatment [40].         
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        They are known to corrode concrete and stonework by the production of acids,
produce greenhouse gases and pollute water by nitrite and nitrate release [40]. However 
they are useful in the WWTPs where they are known to reduce the ammonia content
[40]. This is in turn reduces the risk posed by ammonia to aquatic life, prevents 
eutrophication to some extent and also reduces the oxygen demand in water bodies [40].
         The AOB are broadly classified into two monophyletic groups under protobacteria
[21]. The AOB are known to belong to the gamma and beta subclass of protobacteria 
[21]. Nitrosomonas nitrosa, Nitrosomonas marina, Nitrosomonas europaea, 
Nitrosomonas halophila are some of the strains that belong to the beta class of AOB 
[40]. Nitrosococcus halophilus, Nitrosococcus oceani and Nitrosococcus sp. strains 
belong to the gamma class of AOB [40]. Extensive studies conducted on AOB have been 
able to identify the following diversity of AOB (Table 7) [56]. 
TABLE 7. Genetic diversity of AOB. [56]
Genera Number of species
Nitrosomonas 10 recognized species 
Nitrosococcus 3 recognized species
Nitrosospira 1 recognized species + 4 species indicated by DNA homology studies
Nitrosovibrio 1 recognized species + 1 species indicated by DNA homology studies
Nitrosolobus 1 recognized species + 1 species indicated by DNA homology studies
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A study conducted on the AOB present in the activated sludge of a WWTP reported the 
presence of the following strains: N.mobilis, N.europaea, N.eutropha and N.halophila 
[21]. However Nitrosospira like cells were the dominant species found in the activated 
sludge along with N. mobilis [21].
Fig. 1 lists some AOB strains and their relation to the methane oxidizing bacteria.
FIG. 1. AOB strains and their relationship with methane-oxidizing bacteria. [56]
2.6.2 Oxidation of ammonia. AOB utilize ammonia as an energy source [14]. AOB
oxidize ammonia to nitrite in the WWTPs along with nitrifying bacteria which convert 
the nitrite to nitrate [14]. Since no other autotrophic bacteria are known to catalyze the 
oxidation of ammonia to nitrite, AOB play a very important role in the nitrification 
process in WWTPs [14]. 
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        The conversion of ammonia to nitrite is carried out by principally two enzymes 
namely hydroxylamine oxidoreductase (HAO) and ammonia monooxygenase (AMO)
[14]. HAO and AMO enzymes work in tandem to bring about the oxidation of ammonia 
[14]. 
FIG. 2. Reactions catalyzed by AMO and HAO. “AMO- ammonia monooxygenase, HAO-
hydroxylamine oxidoreductase, P460- cytochrome P460, Q- ubiquinone-8, CycB- teraheme membrane c-
cytochrome, c552- cytochrome c552, ccp- diheme c553 peroxidase, NiR- nitrite reductase, CuCuaa3-
cytochrome oxidase, NOR- nitric oxide reductase, N2OR – nitrous oxide reductase. Solid arrows show 
known pathways. Dashed arrows show hypothesized pathways” [24].
        The oxidation of ammonia to hydroxylamine is initiated by two electrons that are 
brought to AMO [14]. The hydroxylamine is then oxidized to nitrite with the release of 
four electrons [14]. The four electrons are transferred by the HAO to cytochrome 554 
(c554) which is the sole source of energy transfer and biosynthesis for AOB [14].  Out of 
these four electrons, two are used for the regeneration of hydroxylamine and the other 
two electrons are used in the reduction of pyridine nucleotide [14]. The leftover 
electrons are passed on to cytochrome aa3 reductase from c554 or used in the NO and 
N2. The reduction is carried out by NO and N2O reductases [14].
2.6.3 Ammonia monooxygenase. AMO plays an important role in the oxidation of 
ammonia (Fig. 2). AMO is a membrane bound enzyme and oxidizes ammonia to 
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hyrdroxylamine which is further oxidized to nitrite by HAO [24]. Similar to methane 
monooxygenase, AMO is also known for the wide substrate range it catalyzes [24].
AMO is known to degrade aromatic hydrocarbons, alkanes, alkenes and chlorinated 
hydrocarbons [24].
       Ammonia serves as the substrate for the enzyme as compared to ammonium ions 
[14]. The substrates or competitive inhibitors for the AMO enzyme are mostly non-polar 
in nature (Fig. 3) [14]. The different kinds of compounds in the substrate range suggest 
the activity of the enzyme is triggered by oxygen rather than the substrate [14]. The 
oxygen from the AMO enzyme is highly reactive and is known to react with the N-H 
bonds present in ammonia, C-H bonds present in methane and other hydrocarbons [14].
The reactions concerning AMO are of two broad types. The AMO enzyme either 
initiates a dehydrogenase or oxidase reaction or a reductive dehalogenation reaction
[14].     
       
FIG. 3. Types of reactions characterized by AMO. [14]
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         At very low oxygen levels, significant amounts of nitrous oxide, nitric oxide and 
nitrogen gas are produced by AOB [14]. In such cases mostly nitrite is the electron 
acceptor and compounds like pyruvate and hydrogen act as reductants [14]. The growth 
of the organisms under such conditions was observed to be slower than aerobic 
conditions [14]. 
2.6.4 Nitrosomonas europaea. N.europaea belongs to the β-subdivision of the 
protobacteria which is derived from photosynthetic bacteria [28]. Most of the other 
Nitrosomonas and Nitrospira strains belong to the β- subdivision [28]. N.europaea with 
other AOB takes part in the nitrification process which is an important step in the 
biogeochemical nitrogen cycle [4]. However, some by-products of this cycle namely 
gases like nitric oxide and nitrous oxide are essentially green house gases and play a role 
in global warming [4]. But the activity of the microorganisms also provides nitrogen to 
plants and is used in waste water treatment and remediation of contaminated sites [4].
        N.europaea obtains the energy and reductant required for its growth by the 
oxidation of ammonia [4]. The main carbon source for the cell is carbon dioxide [4]. So 
far, it has been observed that N.europaea is not capable of utilizing any other organic or 
inorganic compound as a source of its energy [4]. The study of the bacterium’s genome 
did not show any evidence for the reduction of Fe, CO, H2 or other sources of energy 
[4]. A study has also reported a loss in the activity of N.europaea due to the availability 
of limited ammonia or ammonium ion [51]. 
         Studies have also reported the wide substrate range of N.europaea [6, 25]. Due to 
the AMO enzyme, they are known to catalyze the oxidation of many different aromatic 
and aliphatic organics via co-metabolic degradation (non beneficial mechanism) [6, 25].
        In this study, it is hypothesized that BPA and ibuprofen can be cometabolically 
degraded during the oxidation of ammonia to nitrite (Fig. 4).
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Some of the hydrocarbons that lie in the substrate range of N.europaea are outlined in 
Table 8:
FIG. 4. Hypothesized cometabolic reactions by N.europaea.
TABLE 8. Oxidation of n-alkanes and n-alkenes by N.europaea. [25]
Substrate (n-alkanes) Product
Methane Methanol
Ethane Ethanol
Propane Propan-1-ol, propan-2-ol, both.
Butane Butan-1-ol, butan-2-ol, both
Pentane Pentan-1-ol, pentan-2-ol, both
Hexane Hexan-1-ol, hexan-2-ol, both
Heptane Heptan-1-ol, heptan-2-ol, both
Octane Octan-1-ol, octan-2-ol
Substrate (n-alkenes) Product
Ammonia Oxidation
NH3
+
O2
NADH NAD+
AMO
NH2OH
NADHNAD+
HAO
NO2
-
(Hypothesized) Cometabolic Oxidation
BPA/
Ibuprofen
+
O2
NADH NAD+
AMO
Metabolites or End Products
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TABLE 8. Continued.
Ethylene Ethylene oxide
Propylene Propylene oxide, 2-propene-1-ol, both
1-butene 1,2-epoxybutane, 3-butene-1-ol, 3-butene-
2-ol, all the three
1-pentene 1,2-epoxypentane, 4-pentane-1-ol, 4-
pentane-2-ol, all the three
2-butene (cis) Cis 2,3-epoxybutane, cis 2-butene-1-ol, 
both
2-butene (trans) Trans 2,3-epoxybutane, trans 2-butene-1-
ol, both
       Several other aromatic compounds like benzene, phenol, halogenated aromatic 
compounds like chlorobenzene, bromobenzene, aromatic alcohols like benzyl alcohols, 
cresols, aromatic compounds with nitrogen and oxygen like aniline, acetophenone and so 
on are also degraded by N.europaea [25]. Recently is has been reported that N.europaea
can also degrade estrogens namely estrone, 17 β- estradiol, estriol and 17 α-
ethynylestradiol [46]. Intermediates were also detected at the end of this process and it 
was observed that N.europaea was unable to degrade these intermediates [46].
2.7 COMETABOLISM
2.7.1 Introduction. The biological processes that take place during the degradation of 
organic compounds are primarily of two types. The first kind of process occurs when the
organic compounds are used as the primary substrate or they are the main carbon and 
energy source [35]. The second type of reaction is named cometabolism [35].
      Cometabolism is an important process that takes part in the degradation of several 
toxic compounds in the environment. According to the EPA website cometabolism is 
defined “as a process in which there is a simultaneous metabolism of two compounds 
such that the degradation of the second compound depends on the presence or 
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degradation of the first or the primary compound” [6]. Cometabolism occurs by the 
action of enzymes that are produced by the microorganisms primarily for some other 
purpose [35]. Cometabolism can hence be termed as a “fortuitous reaction” [35].
     Cometabolism may or may not be beneficial to the microorganisms. In some cases 
it can be harmful to the microorganism [35]. Cometabolism can occur if there are 
sufficient numbers of microorganisms to produce the required enzymes [35]. Another 
requirement is the presence of the primary substrate which is the main carbon and 
energy source [35]. It is necessary that the substrate should be present in sufficient
quantity to be able to overcome the toxic effects occurring during cometabolism [35]. In 
several cases this process requires additional energy that is provided by a complex 
enzymatic reaction in the form of NADH or NADPH [35].
        Many monooxygenases and dioxygenases can oxidize many different compounds 
through cometabolic reactions [35]. Many oxygenase-expressing microorganisms, like 
methane oxidizers, toluene oxidizers, ammonia oxidizers and phenol or cresol oxidizers 
are known to catalyze cometabolic reactions [35]. However the microbial behavior of the 
above organisms differs with different organisms [35]. The methane oxidizers that 
express methane monooxygense enzyme are currently one of the most studied micro 
organisms [35].
2.7.2 Competitive inhibition. Competitive inhibition occurs when two compounds are 
oxidized by the same enzyme. Hence, primary and cometabolic substrates become 
competitive substrates [35]. For example, methane monooxygenase (MMO) can oxidize 
both methane and tri-chloro ethylene (TCE). Hence methane and TCE competitively
inhibit each other [35].
        Competitive inhibition can be overcome by supplying the primary substrate at 
regular intervals, just sufficient to induce the enzyme activity [35]. Another way is to 
grow the microorganism on a primary substrate to induce the enzyme and then adding 
secondary substrate to prevent competitive inhibition [35]. 
2.7.3 Transformation product toxicity (TPT). One of the major factors that hinder 
cometabolism is the transformation product toxicity (TPT) [35]. During the course of the 
27
reaction certain intermediate products are formed which are toxic to the microorganisms 
and hence reduce the activity of the cell [35]. It can have the following repercussions: 
(1) Inactivation of the enzyme
(2) Interacts with other cellular components and damages it
(3) Death of the cell 
Transformation capacity (Tc), a measure of TPT is defined as the amount of compound 
that can be transformed before cell inactivation [35]. 
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CHAPTER III
MATERIALS AND METHODS
3.1 CHEMICALS
BPA (99% purity) was obtained from TCI America, Inc., Portland, OR. Ibuprofen 
(USP grade) was obtained from MP Biomedicals, Aurora, OH. Stock solutions (1000, 
100, 10, 1 and 0.1 mg/L) for both Ibuprofen and BPA were prepared in acetone. The 
standards were prepared in 40 ml glass vials. Ethyl ether was purchased from Fisher 
Scientific, Inc., Fair Lawn, NJ. Allythiourea, an inhibitor for the AMO enzyme activity
[45], was bought from Sigma-Aldrich, Inc., St. Louis, MO. Dimethylformamide (DMF) 
and N,O-bis(trimethylsilyl)-trifluoroacetamide (BSTFA) were purchased from Pierce 
Biotechnology, Inc., Rockford, Il. Tetrazotized o-anisidine was purchased from Fluka 
chemicals, Sigma-Aldrich, Inc., St. Louis, MO.
3.2 CULTURE AND GROWTH CONDITIONS
3.2.1 AOB (pure culture). Nitrosomonas europaea culture was provided by Dr. 
Michael R. Hymann, Department of Microbiology, North Carolina State University. The 
culture was grown in sterilized 2L flasks containing 1000ml of a mineral salts medium 
[NH4(SO4)2 , 3.3 g, 0.33g, 0.66g; KH2PO4, 0.4L; NaH2PO4, 0.48g; 1M MgSO4, 0.75ml; 
1 M CaCl2, 0.2ml; 30mM FeSO4/ 50mM EDTA stock solution, 0.33ml; 50mM CuSO4, 
0.01 ml; KH2PO4, 5.44g; Na2CO3, 0.04% in 1000ml] [17]. The flasks were incubated at 
180 rpm at 30°C in the dark. Na2CO3 (0.003M) was the sole carbon source. The culture
was allowed to grow for 3 days before harvesting for experimental use.
3.2.2 AOB (mixed culture). The activated sludge samples were collected from the 
Carter’s Creek WWTP located in College Station and the 36th street WWTP belonging 
to the City of Houston.
3.2.2.1 Activated sludge (combined reactor). The activated sludge from the Carter’s 
Creek WWTP located in College Station was collected from a single reactor that was 
employed for both carbon and nitrogen removal. The single stage reactor was designed 
for an average flow of 2.5 million gallons per day (MGD) while the peak design flow 
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was 7.8 MGD. However the average flow through the aeration basin was recorded to be 
1.5 MGD. The WWTP consisted of four different aeration basins with a length of 88 
feet, width of 33 feet and a depth of 12 feet. Each aeration basin consisted of two 
compartments each with each compartment containing two grids. The influent and the 
return activated sludge entered through the grid nearest to the influent through the 
various compartments of all the aeration basins through holes in the walls between 
chambers. A total of 2,724 grid (ceramic fine bubble) diffusers were distributed over the 
grids with the highest numbers in the grid nearest to the influent. The aeration basin was 
fed through a single influent inlet. The average influent biological oxygen demand 
(BOD) and MLVSS were 202 mg/L and 2057 mg/L respectively. The average influent 
and effluent ammonia concentration was 22 mg/L and 0.35 mg/L. The sludge retention 
time varied between 7 to 12 days.
3.2.2.2 Activated sludge (nitrifying reactor). The Houston WWTP employed a two 
step treatment process where the first step was the carbonaceous treatment and the 
second step was nitrogenous treatment. The WWTP had eight parallel treatment trains 
with each trains consisting of a first step reactor (carbonaceous) and a second step 
reactor (nitrogenous). The carbonaceous reactor (116 feet x 116 feet) consists of four 
compartments (58 feet x 58 feet) with an average side water depth of 14.8 feet arranged 
in series. Each cell had one mixer and a power blower. The second step reactor consisted 
of a reactor (133 feet x 133 feet) with the three compartments; first compartment (66 x 
133 feet), second and third compartment (66 x 66 feet) with an average side water depth 
of 14.8 feet. The first compartment had two mixers and a purge blower while the second 
and third compartment had one of each.
          Each reactor was fed independently from the same source with flow splitter box. 
Each reactor was designed to treat an average flow 25 MGD and a peak flow of 50 
MGD. The influent average temperature, BOD and MLVSS were recorded as 25°C, 165 
mg/L and 70 %. The average influent and effluent ammonia was 17 mg/L and 2.8 mg/L. 
The carbonaceous reactor employed 1 day old sludge while the nitrogenous reactor used 
30 days old sludge. 
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3.3 DEGRADATION TESTS WITH PURE CULTURE
The degradation tests were conducted in 1000 ml flasks with different volumes for 
different experiments. Appropriate amounts of the compound (BPA and ibuprofen) were 
added from the stock solutions that were previously prepared. BPA was added along 
with the acetone while acetone was evaporated in the case of ibuprofen. Experiments 
conducted earlier with acetone evaporation resulted in very low concentrations of BPA. 
BPA and ibuprofen were then allowed to dissolve over 3 days in a dark room since BPA 
is photosensitive. Due to the low detection limit of the GCMS, higher experimental 
concentrations of BPA and ibuprofen were used as compared to the environmental and 
toxicity concentrations [3, 10, 30, 34, 39, 42, 44].  
          The pre-cultivated culture was centrifuged at a speed of 167 rps to spin down most 
of the cell suspended in the media. The cell was then washed using a phosphate buffer 
solution (0.05M NaH2PO4 and 0.002M of MgSO4) for one of the experiments. The cell 
was further re-suspended in the media and added to the 1000ml bottles containing BPA 
or ibuprofen. The optical density in the 1000ml bottles was maintained at 0.076 or 0.4 
using a spectrophotometer (Agilent 8453, USA) at 600nm. The corresponding MLVSS 
for the two optical densities was 229 mg/L and 1385 mg/L. To achieve faster 
degradation, in stead of using the lower cell mass, a higher cell mass was used in the 
later experiments
          The experiments were conducted in different conditions in the 1000 ml flasks. The
activity of AMO enzyme was inhibited by adding an AMO inhibitor, allylthiourea (10 
mg/L), into two of the flasks.  Sodium formate (20mM) was added to two additional 
flasks to provide reducing energy for the biodegradation process. Sterilized cells were 
used for the sterile control for the purpose of abiotic activity. The 1000ml flasks were 
then kept on a shaker for thorough mixing at 180 rpm at 30°C in the dark. Samples were 
drawn at regular intervals for analyses.
         The initial experiment was conducted to examine if BPA could be degraded by 
N.europaea. A similar experiment was conducted with resting cells. Both the 
experiments and the results are described in detail in the appendix.
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3.3.1 Experiments on BPA.
3.3.1.1. BPA (0.75 mg/L). A BPA concentration of 0.75 mg/L and a final volume of 150 
ml was used for the experiment. The N.europaea culture for the experiment was grown 
on two different ammonia concentrations of 5mM and 10mM. This was done to compare 
the differences in the degradation of BPA by cells grown on different ammonia 
concentrations. The cells grown on 5mM ammonia were suspended in media containing 
5mM ammonia and the cells grown on 10mM ammonia were suspended in media 
containing 10mM ammonia. The cells were maintained at a higher optical density of 0.4
(1,385 mg/L) for the current experiment. The experiment excluded the addition of 
sodium formate and inhibitor to the flasks.
3.3.1.2. BPA (1 mg/L). This experiment was conducted with BPA (1 mg/L) and the final 
volume was 150 ml. The cells for the experiment were grown on an ammonia 
concentration of 10mM and with an optical density of 0.4 (1385 mg/L). 
3.3.2 Experiments on ibuprofen. The experiments on ibuprofen were conducted for 
two concentrations of 0.8 mg/L and 0.4 mg/L (Appendix I). For both the experiments an 
optical density of 0.4 (MLVSS = 1385 mg/L) and a final volume of 150 ml was used. 
The cells were grown on an ammonia concentration of 10mM.
3.4 DEGRADATION TESTS WITH ACTIVATED SLUDGE
The experiments with the activated sludge were conducted on BPA (1mg/L) and 
ibuprofen (0.5 mg/L). The activated sludge in the first experiment was obtained from a 
combined reactor with both oxidation and nitrification taking place in the same reactor. 
For the second experiment the activated sludge was obtained from the nitrification tank.
         The experiment was conducted on similar lines as the pure culture. All the 
experiments were conducted with the compounds BPA and ibuprofen, with and without 
the presence of inhibitor allylthiourea and by using sterilized activated sludge for the kill 
control. The addition of AMO inhibitor would allow for examining whether AMO 
enzymes play a role on BPA and/or ibuprofen biodegradation. The MLVSS of the sludge 
was first measured and adjusted to 1000 mg/L in a final volume of 150 ml and 300 ml. 
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The sludge was washed with a phosphate buffer solution (0.05M NaH2PO4 and 0.002M 
of MgSO4) after centrifuging it.
3.5 BPA AND IBUPROFEN ANALYSIS
5 ml samples were collected from the 1000ml flasks over 30 hours. Samples were 
collected every 24 hours for the mixed culture experiment. For the pure culture 
experiments samples at shorter intervals were collected. The first sample was always 
collected at 0 hours. 100 μl of concentrated H2SO4 (17.8 M) was added to each of the 
samples to stop microbial activity. The samples were then stored at 4°C. 
       The samples were diluted by the addition of 5 ml of DI water before ether 
extraction. By adding 10 ml ethyl ether to the samples, BPA and ibuprofen were 
extracted from ether. For complete extraction, the samples were placed on the shaker for 
24 hours at the high speed setting. Extracted 500 μl sample along with the standards 
prepared in acetone were evaporated overnight. 450 μl of DMF and 50 μl of BSTFA 
were added to derivatize the samples for two hours.
        The derivatized samples were injected into an Agilent Technologies 6890N 
Network Gas Chromatography System (Santa Clara, CA) consisting of a HP-5MS 
column (30.0m x 250μm (i.d) and 0.25μm thickness), an Agilent 5873 Network mass 
selective detector and an Agilent MSD ChemStation. Helium is used as the carrier gas at 
40 cm/s. The injector temperature is 250°C.  The oven temperature is initially set at 
80°C and then ramped at 30°C/min to 280°C and held for 3 min. The selective ion 
monitoring mode was used with the selected ions of 357 m/z and 372 m/z for BPA and 
263 m/z and 278 m/z for ibuprofen. The detection limit for BPA and ibuprofen was 0.01 
mg/L.
3.6 NITRITE AND NITRATE ANALYSIS
Samples of up to 7-10ml were collected for ammonia, nitrate and nitrite analyses.
The samples were filtered and stored at -20°C before use. The standard solutions ranging 
from 1 mg/L to 300 mg/L were prepared using sodium nitrite and sodium nitrate in DI 
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water as the detection limit of the instrument was 1 mg/L. Samples of 10μl were injected 
for analysis to a DIONEX, DX-80 Ion Chromatograph (IC) (Sunnyvale, CA) equipped 
with an IonPac AS14A- 5μm analytical column (3 x 150 mm) for anion separation. An 
eluent solution of 0.16M Na2CO3 and 0.02M NaHCO3 was used at a flow rate of 0.5 
ml/min.
3.7 AMMONIA ANALYSIS
The ammonia analysis was conducted on an Accumet SN5244072P ammonia 
selective probe (Houston, TX). The standard solutions were prepared with ammonium 
sulphate in DI water from 1 mg/L to 500 mg/L. The detection limit of the instrument was
1 mg/L. 5ml of the samples were diluted to 50ml. 500 μl of 10N NaOH was added to the 
sample in order to convert NH3 to NH4
+ ion. The concentration of ammonia was 
determined by comparing to the standard curves.
3.8 NAPHTHALENE OXIDATION TEST
Naphthalene oxidation tests were conducted as described by Chu and Alvarez-
Cohen [16] to measure non-specific monooxygenase activity. The teat was based on the 
fact a non-specific monooxygenase like AMO can oxidize naphthalene to 1- or 2-
naphthol which can interact with tetrazotized o-anisidine to produce purple color [16].         
          Naphthalene was prepared by adding naphthalene crystals in DI water and placing 
it on the shaker for over 24 hours. The tests were conducted in vials by adding 1 ml 
samples, 1 ml of naphthalene solution and 1 ml of sodium formate (20mM). The vial 
was then incubated in the dark at 30°C at 180 rpm for one hour. After adding 100 μl of 
tetrazotized o-anisidine 0.2% (w/v) solution, the optical density was measured at a 
wavelength of 530 nm by using an Agilent 8453 photospectrometer (Englewood, CO). 
The measurements were made within two minutes after the addition of the tetrazotized 
o-anisidine solution as the absorbance is known to increase beyond two minutes. The 
controls were prepared without cells. The blanks were prepared by adding DI water and 
cells. 
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CHAPTER IV
RESULTS
         This study was conducted to assess the degradation capability of BPA and 
ibuprofen by Nitrosomonas europaea. Experiments were designed with an AMO 
inhibitor (allylthiourea), addition of reducing energy (sodium formate) and/ or different 
ammonia concentrations (5mM and 10mM).
4.1 BIODEGRADATION OF BPA AND IBUPROFEN BY N.europaea
4.1.1 Effects of ammonia concentration on BPA degradation. Experiments were 
conducted on BPA (0.75 mg/L) using cells grown on ammonia of concentration 5mM 
and 10 mM. BPA was removed completely by 3.5 hours for 10 mM ammonia (Fig. 4-1a) 
and in 48 hours for 5 mM ammonia (Fig. 4-1a). Experiments were also conducted with 
resting cells which are explained in Appendix I.
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FIG. 4-1a. Degradation of BPA (0.75 mg/L) with ammonia concentrations of 5mM, 10mM.
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The cell activity with respect to nitrite production was higher (0.14 absorbance) for 
10 mM ammonia while it was lower (0.078 absorbance) for 5 mM ammonia (Fig. 4-1b). 
The nitrite production and ammonia oxidation was completely achieved within 3.5 hours 
(Fig. 4-1c and d), regardless of the ammonia concentrations.
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FIG. 4-1b. Naphthalene oxidation assay for cells grown on 5mM, 10mM ammonia and BPA 0.75 
mg/L.
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FIG. 4-1c. Production of nitrite by cells grown on 5mM, 10mM ammonia with BPA (0.75 mg/L).
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FIG. 4-1d. Oxidation of ammonia by cells grown on 5mM, 10mM ammonia with BPA (0.75 mg/L).
4.1.2 Cometabolic degradation of BPA by AMO. The experiment was conducted with 
two BPA concentrations of 1.6 mg/L with lower cell mass (Appendix I) and 1 mg/L with 
higher cell mass. The experiment was conducted with N.europaea grown on 10mM 
ammonia with the optical density (OD) adjusted to 0.4 (1385 mg/L). 
         BPA was degraded from 1 mg/L to 0.2 mg/L confirming the results from the 
previous experiment as explained in section 4.1.1. The AMO inhibitor successfully 
inhibited the reaction as there was no reduction in BPA concentration (Fig. 4-2a). The 
decrease in the cell activity can be observed from the naphthalene oxidation assay 
conducted (Fig. 4-2b). 
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FIG. 4-2a. Degradation of BPA (1 mg/L) with and without AMO inhibitor allylthiourea.
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FIG. 4-2b. Naphthalene oxidation assay for BPA (1mg/L) and optical density of cell 0.4.
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The nitrite production and ammonia oxidation can be seen in Fig 4-2c and Fig 4-2d.
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FIG. 4-2c. Nitrite production for BPA (1 mg/L) with initial ammonia concentration of 10mM.
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FIG. 4-2d. Ammonia oxidation with BPA (1 mg/L) and initial ammonia concentration of 10 mM.
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4.1.3 Cometabolic degradation of ibuprofen by AMO. The experiments on ibuprofen 
were conducted on ibuprofen of concentrations 0.8 mg/L and 0.42 mg/L (Appendix I). 
The cells were grown on 10 mM ammonia and adjusted to an OD of 0.4.  There was no 
degradation of ibuprofen observed as seen in Fig. 4-3a.
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FIG. 4-3a. Degradation of ibuprofen of concentration 0.8 mg/L.
From Fig. 4-3b, it was found that the absorbance (cell activity) was very low (0.01) for 
ibuprofen of 0.8 mg/L.
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FIG. 4-3b. Naphthalene oxidation assay for ibuprofen of 0.8 mg/L with an initial ammonia 
concentration 10 mM.
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FIG. 4-3c. Nitrite production with initial ibuprofen concentration of 0.8 mg/L, the culture grown on 
10mM ammonia.
The nitrite production and ammonia oxidation was < 10 mg/L (Fig. 4-3c and d) 
corresponding to the low AMO activity. 
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FIG. 4-3d. Ammonia oxidation by N.europaea grown on 10mM ammonia with initial BPA 
concentration of 0.8 mg/L 
         Table 9 contains the rates of degradation for the experiments conducted on the 
BPA degradation. The rates were calculated by dividing the difference in concentration 
between the 0 hour sampling point and the next sampling point (4 hours and 1 hour) over
time. In order to normalize the degradation rates the rates so obtained were divided by 
the cell mass used for the experiments. The highest rate of degradation was observed for 
the cells grown on 10 mM ammonia and BPA of concentration 1 mg/L.
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TABLE 9. Degradation rates of BPA by pure culture.
Experiment Initial specific degradation 
rate (mass BPA/ mass 
MLVSS x h)
BPA of concentration 0.75 mg/L with MLVSS 
138.5 mg/L and ammonia concentrations of:
1. 5 mM
2. 10 mM
1. 1.27 E -04
2. 1.35 E -04
BPA of concentration 1 mg/L with MLVSS 1385
mg/L and initial ammonia concentration of 10 mM
            5.13 E -04
4.2 BIODEGRADATION OF BPA AND IBUPROFEN BY ACTIVATED SLUDGE 
(MIXED CULTURE)
4.2.1 Biodegradation by activated sludge from one stage aeration tank. BPA (1 
mg/L) and ibuprofen (0.5 mg/L) were subjected to degradation by activated sludge from 
a reactor that was designed for both oxidation and nitrogen removal. The BPA was 
degraded from 1 mg/L to 0.2 mg/L in the presence and absence of the inhibitor 
allylthiourea (Fig. 4-4a). However ibuprofen was removed completely at the end of the 
2nd day (Fig. 4-4b). 
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FIG. 4-4a. Degradation of BPA (1 mg/L) by activated sludge from a single stage aeration tank.
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FIG. 4-4b. Degradation of ibuprofen (0.5 mg/L) by activated sludge from a single stage aeration 
tank.
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There was no production of nitrite but nitrate production commenced on the 6th day for 
BPA and on the 5th day for ibuprofen (Fig. 4-4c and d). Ammonia oxidation was 
observed after the 2nd day for BPA (Fig. 4-4e) while the ammonia oxidation was 
completed by the 2nd day for ibuprofen (Fig. 4- 4f).
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FIG. 4-4c. Nitrate production by activated sludge from a single stage aeration tank with BPA (1 
mg/L).
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FIG. 4-4d. Nitrate production by activated sludge from a single stage aeration tank with ibuprofen 
(1 mg/L). 
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FIG. 4-4e. Ammonia oxidation by activated sludge from a single stage aeration tank with BPA (1 
mg/L).  
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FIG. 4-4f. Ammonia oxidation by activated sludge from a single stage aeration tank with ibuprofen 
(1 mg/L). 
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4.2.2 Biodegradation by activated sludge from dual stage treatment process 
(nitrifying tank). Degradation tests were conducted on BPA of 1 mg/L and ibuprofen of 
0.5 mg/L with two stage activated sludge. In both the cases BPA and ibuprofen were 
completely removed from the system (Fig. 4-5a and b). 
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FIG. 4-5a. BPA (1mg/L) degradation by two stage activated sludge.
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FIG. 4-5b. Ibuprofen (0.5 mg/L) degradation by two stage activated sludge.
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FIG. 4-5c. Nitrate production by two stage activated sludge and BPA of 1 mg/L.  
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FIG. 4-5d. Nitrate production by two stage activated sludge and ibuprofen of 0.5 mg/L.
The nitrate production and ammonia oxidation is given by Fig. 4-5c and d and Fig. 4-5e 
and f respectively. 
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FIG. 4-5e. Ammonia oxidation by two stage activated sludge and BPA of 1.0 mg/L.
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FIG. 4-5f. Ammonia oxidation by two stage activated sludge and ibuprofen of 0.5 mg/L. 
         Table 10 gives the degradation rates of the experiments conducted with activated 
sludge on both BPA and ibuprofen. The degradation rates were calculated by 
considering the initial change in concentration of the compounds over the period 
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required for the change in concentration. The rate was then normalized by dividing it by 
the MLVSS of the activated sludge.
TABLE 10. Degradation rates of the experiments conducted with activated sludge on 
both BPA and ibuprofen.
Experiment Initial specific degradation rate 
(mass BPA/ mass MLVSS x h)
BPA of concentration 1 mg/L with activated 
sludge from combined reactor with MLVSS 1000 
mg/L.
1. BPA only
2. BPA + Inhibitor
1. 2.7 E -04
2. 2.66 E -05
BPA of concentration 1 mg/L with activated 
sludge from nitrification tank with MLVSS 1000 
mg/L.
1. BPA only
2. BPA + Inhibitor
1. 5.25 E -04
2. 3.16 E -04
Ibuprofen of concentration 0.5 mg/L with activated 
sludge from combined reactor with MLVSS 1000 
mg/L.
1. Ibuprofen only
2. Ibuprofen + Inhibitor
1. 2.6 E -04
2. 2.65 E -04
Ibuprofen of concentration 0.5 mg/L with activated 
sludge from nitrification tank with MLVSS 1000 
mg/L.
1. Ibuprofen only
2. Ibuprofen + Inhibitor 
1. 2.37 E -04
2. 2.49 E -04
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CHAPTER V
DISCUSSION
         Biodegradation is very broadly known as the process by which organic compounds 
are degraded by living organisms. This naturally occurring process can be utilized for 
the removal of pollutants from the environment. This study deals with the 
biodegradation of BPA and ibuprofen with ammonia oxidizing bacterium N.europaea
and activated sludge from WWTPs. 
5.1 BIODEGRADATION OF BPA AND IBUPROFEN BY N.europaea
        N.europaea is one of the most commonly found AOB in nature [28]. As described 
in Chapter II, it has been utilized for the degradation of several compounds and 
pollutants. The activity (non-beneficial mechanism) of the AMO enzyme is known to be 
mainly responsible for the degradation [25]. Several of the compounds in the substrate 
range of the enzyme are aromatic in nature [25]. Both BPA and ibuprofen are aromatic 
compounds and hence are similar to some of the compounds in the substrate range of the 
AMO enzyme [25].
5.1.1 Degradation of BPA by N.europaea. BPA was degraded successfully by 
N.europaea with different ammonia concentrations (Fig. 4-1a and 4-2a) and with a lower 
cell mass (Appendix I). The oxidation of ammonia and production of nitrite could be 
observed only in the samples without inhibitor (Fig. 4-1c and d and 4-2c and d).  
However there was no degradation of BPA observed in the presence of the AMO 
inhibitor allylthiourea (Fig. 4-1a and 4-2a). This means that allylthiourea successfully 
inhibited the AMO enzyme. The results also indicate that AMO enzyme was active in 
the samples without inhibitor and was likely an important step in BPA degradation. This 
view was further proven by the naphthalene oxidation assay that showed high AMO 
activity at the start of the experiment and decreased as the degradation of BPA 
proceeded (Fig. 4-1b and 4-2b).
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5.1.2 Effect of ammonia concentration. The ammonia concentration, the presence or 
absence of ammonia during the reaction and growth of the bacteria impacted the 
degradation reaction. There was no BPA degradation in the experiment with resting 
cells. The AMO activity was very low in the absence of ammonia (Appendix I). 
Contrary to one study reports no loss in ammonia oxidizing activity in the absence of 
ammonia [51]. From the results of the current study, the presence of ammonia seems to 
be essential for the degradation reaction to occur as it has a bearing on the AMO activity.
         Similarly cells were also grown on two ammonia concentrations of 5 mM and 10 
mM. An earlier study had observed higher degradation at 5 mM ammonia concentration 
[24]. It could be seen that the cells grown on 10 mM had a higher AMO activity of 0.14 
compared to the cells grown on 5mM (0.07) based on the naphthalene oxidation tests (in 
Fig. 4-1b). Corresponding to the higher AMO activity as there was complete removal of 
BPA within the first 3 ½ hours for the cells grown on 10mM ammonia (Fig. 4-2b). The 
complete removal took a longer time of 48 hours for 5mM ammonia cells (Fig. 4-2a).
The normalized initial specific ammonia oxidation rates for 5mM ammonia and 10mM 
ammonia was reported to be 5.51x10-3 (mass ammonia/mass MLVSS*h) and 1.92x10-2
(mass ammonia/mass MLVSS*h) respectively. Similarly the normalized initial specific 
nitrite production rates were 2.27x10-3 (mass nitrite/mass MLVSS*h) and 5.98x10-3
(mass nitrite/mass MLVSS*h) for 5mM and 10mM ammonia respectively. From the 
above rates, the ammonia oxidizing ability of N.europaea was seen to be higher for the 
ammonia concentration of 10 mM. This confirms an earlier finding that reported the loss 
of ammonia oxidizing activity in AOB under ammonia limiting conditions [51]. The 
concentration of ammonia thus is an important parameter to be considered in the 
experiment design.
5.1.3 Degradation of ibuprofen by N.europaea. There was no degradation of ibuprofen 
observed in both the experiments conducted. Even with the higher AMO activity (Fig. 4-
3b) in the case of the second experiment, there was no oxidation of ibuprofen (Fig. 4-
3a). However there was ammonia oxidation and nitrite production in the absence of the 
inhibitor indicating the presence of AMO. 
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           The AMO enzyme oxidizes organics by inserting an oxygen atom between the 
carbon atoms. Due to the difference in the structure of BPA and ibuprofen, a difference 
in the action of the enzyme on the two compounds is expected. Accordingly, it is 
probable that AMO is unable to oxidize ibuprofen.
         In the case of higher concentration of ibuprofen, the AMO activity was very low 
(Fig. 4-3b) which could be due to the toxicity of ibuprofen to the bacteria. However no 
studies have reported the toxicity effects of ibuprofen on bacteria.
5.2 BIODEGRADATION OF BPA AND IBUPROFEN BY ACTIVATED SLUDGE
         It is known from previous literature that the BPA removal efficiency can be greater 
than 90% and the ibuprofen removal greater than 95% in WWTPs [11, 42, 49]. A major 
portion of the removal of these compounds in WWTPs has been attributed to 
biodegradation [11, 42, 49]. 
        The activated sludge from WWTPs is known to be the home of many different 
kinds of bacteria including ammonia oxidizing bacteria [46]. BPA was found to be 
degraded by the pure culture N.europaea while ibuprofen was not. In order to test the 
degradability of BPA and ibuprofen by the mixed culture, experiments were conducted 
with activated sludge.
         The activated sludge was obtained from two different types of WWTPs. The first 
experiment was conducted with activated sludge obtained from the local WWTP in 
College Station. The sludge was collected from a single reactor that was devoted to both 
BOD and nitrogen removal. The second experiment was conducted with the activated 
sludge obtained from the Houston WWTP. The Houston WWTP consisted of two stage 
process, in which one tank was devoted to BOD removal and the other tank to nitrogen 
removal. The activated sludge for the experiment was obtained from the nitrification 
tank. Hence it was expected that the AOB population in the activated sludge from the 
nitrification tank was much higher than the local WWTP.
5.2.1 Biodegradation of BPA and ibuprofen by activated sludge from combined 
reactor. BPA was degraded by the activated sludge from 1 mg/L to 0.2 mg/L by the 3rd
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day and ibuprofen was completely removed by the 2nd day. Hence both the compounds 
were degraded by the sludge from the combined reactor. 
         Degradation was observed even in the presence of the inhibitor allylthiourea. Since 
allylthiourea inhibits AMO or AOB, the degradation in this case could be attributed to 
other organisms present in the sludge. The production of nitrate started a day or two after 
ammonia oxidation suggesting the presence of other organisms which could have 
utilized ammonia. The combined reactor was known to have a lower number of AOB.
5.2.2 Biodegradation of BPA and ibuprofen by two stage activated sludge. BPA and 
ibuprofen were completely removed by the two stage activated sludge within the first 2-
3 days. Hence both the compounds were successfully degraded by the activated sludge.
        Once again degradation was observed even with the addition of AMO inhibitor 
allylthiourea. Since the activated sludge was obtained from the nitrification tank of the 
WWTP, a higher AOB population in the nitrification tank was expected as compared to 
that from the combined aeration tank used. Despite the inhibition of activity of AOB by 
allylthiourea faster degradation of both the compounds was observed. This further 
strengthens the theory that several other organisms play an important role in the 
degradation reactions.
        From previous literature, BPA removal by bacteria isolated from river water and 
activated sludge varied between 2- 4 days [20, 22, 23, 32, 43]. The results from the 
current study were similar with BPA being removed by the 3rd day from activated sludge 
from the combined reactor and from the 2-3rd day from the two stage reactor. Ibuprofen 
too was degraded after a span of 2-3 days from a past study by Sphingomonas sp. strain 
[37]. Similar to the previous results ibuprofen removal by the combined reactor was 2 
days and 2-3 days by the single reactor. 
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CHAPTER VI
CONCLUSION AND FUTURE STUDIES
          There were two main goals that were achieved by this study. The first was to 
characterize the degradation of BPA and ibuprofen by a pure culture N.europaea. The 
second was to observe their degradation by activated sludge from two WWTPs. The 
results and findings of the study are summarized below.
          The degradation studies on BPA and ibuprofen by the pure culture N.europaea
was summarized in Chapter IV. It was found that BPA with a concentration up to 1.6 
mg/L was degraded to more than 80% in the experiments on the pure culture. Variations 
in the experimental setup were introduced to the experimental setup by changing the cell 
mass, growing the culture on different ammonia concentrations and using resting cells. It 
was observed that both ammonia and BPA were oxidized by N.europaea during the 
course of the experiment. However, BPA was not be degraded by resting cells probably 
due to the absence of ammonia. Further, the addition of formate to provide reducing 
energy seemed unfavorable for the reaction (Appendix I). Also the AMO inhibitor 
allylthiourea was able to inhibit the oxidation of BPA in all the experimental setups. Due 
to the inhibition of the AMO enzyme there was no ammonia oxidation or nitrite 
production observed.
          It was observed from the tests conducted on ibuprofen that the compound was not 
degradable by the pure culture. Experiments were conducted at two concentrations, 1
mg/L and 0.5 mg/L. At the higher concentration, low AMO activities indicated by the 
naphthalene oxidation assay supported by low ammonia oxidation and nitrite production
were observed. In the case of the lower concentration, even though the AMO activity 
was high there was no degradation of ibuprofen. However this did not interfere with 
oxidation of ammonia to nitrite. 
         The pure culture experiments were followed by the experiments with the mixed 
culture. The first set of experiments were conducted with activated sludge from a 
combined reactor for both BOD and nitrogen removal. While BPA was degraded to 
more than 80% within 3 days ibuprofen was completely degraded by the 2nd day by the 
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activated sludge. The second experiment was conducted with activated sludge from the 
nitrification tank. Both BPA and ibuprofen were completely degraded by the end of the 
2nd day.
          BPA degradation by N.europaea varied with the experimental conditions. 
Complete removal by cells grown on 10mM was under 4 hours which was faster than the 
removal in 2 days accomplished by activated sludge. However complete removal by 
cells grown on 5mM took a longer time of 30 hours. The reported value of Km for 
ammonia from previous literature was 1.34mM [24]. In comparison the normalized 
initial specific ammonia oxidation rate from 5mM ammonia which was lesser than the 
previous reported. In the case of 10mM ammonia the value of 1.92mM was calculated 
which is very close to the reported value. The faster degradation by the pure culture 
could be attributed to the usage of higher cell mass which could be higher than the AOB 
population in the activated sludge. In the case of ibuprofen there was no degradation 
achieved by the pure culture while ibuprofen was completely degraded by the activated 
sludge within 2-3 days.        
    
6.1 FUTURE STUDIES
The pure culture experiments conducted as a part of this study did not include an 
examination of the kinetic parameters involved in the oxidation of BPA. The main focus 
of the study was to examine the possibility of BPA biodegradation. During the course of 
the study, there was no BPA degradation observed by resting cells. The resting cell 
experiment could be repeated with a higher cell mass and with a lower BPA 
concentration to confirm the result obtained. 
          The result obtained from the experiment conducted with sodium formate was 
unexpected. An experiment could be designed to investigate the role played by an 
external energy source like sodium formate on the reaction. Some of the other 
unanswered questions from the study such as the metabolites from the reaction, the 
reaction pathway and the toxicity of the products to the bacteria require further 
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investigation. Further, similar degradation experiments could be with N.europaea on 
other organic contaminants that have similar chemical structure as BPA. 
          Since it was found that ibuprofen could not be degraded by N.europaea, similar 
experiments can be conducted with other AOB or some other non AOB. Further the 
degradation capability of N.europaea with respect to other pharmaceuticals compounds 
detected in the environment can found out. Since N.europaea is an important AOB 
found in WWTPs, it can be applied in WWTPs for the removal several other important 
environmental contaminants.
          Further BPA and ibuprofen were completely degraded by the organisms present in 
the activated sludge from both WWTPs. However a faster and more complete removal 
of both compounds was observed from the nitrification tank. This could be due to the 
presence of higher number of AOB indicating that they do have role to perform in the 
degradation. However there was degradation observed even with the addition of the 
AMO inhibitor in both experiments. No nitrite production was observed in the samples 
from both the WWTPs as the ammonia was converted to nitrate. This indicates the role 
played by other organisms in the activated sludge. Hence studies can focus on
understanding the role played by other organisms in the degradation occurring in 
WWTPs even though they are extremely complex. 
          These studies showed that AOB can cometabolically degrade BPA but not 
ibuprofen.  It is possible to promote a higher AOB population in WWTP to enhance 
BPA removal. For example, by adjusting operating parameters, such as the sludge 
retention time and the C/N ratio, might be able to stimulate the growth of AOB and 
thereby achieve maximum removal of BPA from WWTPs. Consistent with other 
reports, this study observed complete degradation of ibuprofen by activated sludge, 
suggesting that ibuprofen-degrading cultures and/or consortia might be ubiquitous in 
activated sludge systems.  Interestingly, only two strains capable of degrading ibuprofen 
have been isolated [5, 37]. Thus, more studies are needed to better understand the 
identity and characteristics of ibuprofen-degrading cultures in activated sludge. 
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Furthermore, studies are needed to examine other potential ibuprofen degradation 
pathways by various organisms in surface water, sediments, and soils.  
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APPENDIX I
1. BPA (1.6 mg/L)
 The degradation test was conducted in 1000ml flasks with a final volume of 300ml and 
optical density of 0.076 or MLVSS of 229 mg/L. The cells were washed with phosphate 
buffer solution for this experiment only. A concentration of 1.6 mg/L BPA was 
maintained throughout the degradation test. The setup contained 8 flasks of which 2 
flasks contained BPA with the culture. The inhibitor allylthiourea was added to two 
more flasks and sodium formate to two more. The final set of flasks contained the kill 
control.
          Degradation of BPA from 1.6 mg/L to 0.1 mg/L was observed (Fig. 7-1a) with no 
degradation in the presence of the inhibitor. However degradation was observed after a 
period of 20 hours possibly due to the low cell mass used in the experiment. The nitrite 
and ammonia concentrations are shown in Fig 7-1b and 7-1c. There was no nitrite 
production or ammonia oxidation observed in the presence of the inhibitor.
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FIG. 7-1a. Degradation of BPA (1.6 mg/L) with and without AMO inhibitor allylthiourea.
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FIG. 7-1b. Nitrite production for BPA (1.6 mg/L) with initial ammonia concentration of 50mM.
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FIG. 7-1c. Ammonia oxidation with BPA (1.6 mg/L) and initial ammonia concentration of 50 mM.
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2. Effects of formate on BPA degradation 
20mM sodium formate was added to provide reducing energy for the degradation of 
BPA (1.6 mg/L). There was no degradation observed with addition of formate (Fig. 7-
2a) while BPA was degraded from 1.6 mg/L to 0.12 mg/L in the absence of formate. The 
nitrite production and ammonia oxidation is given by Fig. 7-2b and c.
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FIG. 7-2a. Degradation of BPA (1.6 mg/L) with and without the addition of 20 mM sodium   
formate. 
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FIG. 7-2b. Nitrite production with and without the addition of 20 mM sodium formate.
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FIG. 7-2c. Ammonia oxidation with and without the addition of 20 mM sodium formate.
3. BPA experiment with resting cells
The resting cells are cells which are first grown in a media containing the primary 
substrate that the cells utilize as an energy source for their growth. This is done to induce 
the production of AMO enzyme in the cells [44]. After this stage the cells are starved of 
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their energy source by transferring them to a media without the primary substrate [44]. 
The organisms are then forced to use the other available compounds for their growth 
requirements [44]. 
         The cells for the experiment were grown on 50 mM ammonia and then re-
suspended in the media without ammonia. The optical density and MLVSS in a final 
volume of 300ml was 0.076 and 229 mg/L respectively. The experimental setup 
excluded the inhibitor allylthiourea.
        From the results (Fig. 7-3a) it could be seen that there was no BPA degradation 
observed. Also the cell activity measured by the naphthalene oxidation assay was low as 
shown in Fig. 7-3b.
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FIG. 7-3a. Degradation of BPA (0.6 mg/L) with resting cells (absence of ammonia).
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FIG. 7-3b. Naphthalene oxidation assay for resting cells (absence of ammonia).
4. Ibuprofen (0.42 mg/L) degradation experiment
Degradation experiment with ibuprofen of lower concentration was repeated after the 
experiment with higher concentration in Chapter IV. There was no degradation observed 
as seen in Fig. 7-4a. Fig. 7-4b shows the decrease in cell activity measured by 
naphthalene oxidation assay. Similarly there was negligible amount of nitrite production 
and ammonia oxidation (Fig. 7-4c and d).
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FIG. 7-4a. Degradation of ibuprofen of 0.42 mg/L.
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FIG. 7-4b. Naphthalene oxidation assay for ibuprofen of 0.42 mg/L with an initial ammonia 
concentration 10mM.
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FIG. 7-4c. Nitrite production with initial ibuprofen concentration of 0.42 mg/L , with cells grown 
on 10 mM ammonia. 
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FIG. 7-4d. Ammonia oxidation by N.europaea grown on 10mM ammonia with initial ibuprofen
concentration of 0.42 mg/L .
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